For more information about EFFEXOR XR, you can continue to the site here.
See full Prescribing Information, including boxed warning, and Medication Guide for patients.
Important Safety Information
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. EFFEXOR XR® (venlafaxine HCl) is not approved for use in children and teens.
PRISTIQ, introduced in 2008, is another product from Wyeth approved by the FDA for the treatment of major depressive disorder in adults. Find out more.
PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.
Choose the topics for your guide from the checklist below — or from the guide tool on pages throughout the site. The topics you select will be highlighted on this page.
You can always review your choices and add or delete information before you print. Only the topics you choose will be printed on your guide.
Review those issues that concern you. Take your guide to appointments with your health care professional.
Close
Fill in the information below to send an e-mail message and a link to this page.
Recipient's e-mail address
Your e-mail address
Send
This form does not collect your information. To learn more about our use of your information and your rights, please consult our Privacy Policy.
A message has been sent to your intended recipient with a link to this page. He or she will receive it shortly.
Thank you.